Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition

Endocrine Reviews

Volumn 27, Issue 2, 2006, Pages 101-140

  Veldhuis, Johannes D ^a   Roemmich, James N ^b   Richmond, Erick J ^c   Bowers, Cyril Y ^d  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c National Children's Hospital   (Costa Rica)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ESTRADIOL; GONADOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; NEUROPEPTIDE; PEGVISOMANT; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOSTATIN; TESTOSTERONE;

ADAPTATION; ADULTHOOD; CHILDHOOD; CONVERGENT EVOLUTION; DRUG ACTIVITY; DRUG EFFECT; GENE DISRUPTION; GENE MUTATION; GENETIC DISORDER; GENETIC LINKAGE; GROWTH; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NEUROENDOCRINE SYSTEM; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN INTERACTION; PUBERTY; REPRODUCTION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

AGING; ANIMALS; FEMALE; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; GONADS; GROWTH; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMUS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LUTEINIZING HORMONE; MALE; PERIODICITY; PITUITARY GLAND; PUBERTY; SEX CHARACTERISTICS; SEXUAL MATURATION;

EID: 33645517241     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2005-0006     Document Type: Review

References (427)

1. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
2. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
3. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY 2005 Endocrine control of body composition in infancy, childhood and puberty. Endocr Rev 26:114-146
4. van der Lely AJ, Tschop M, Heiman ML, Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
5. Haymond MW, Mauras N 1996 The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans. Horm Res 46:202-207
6. Hwa V, Oh Y, Rosenfeld RG 1999 The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761-787
7. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232
8. Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M 2001 Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107:1571-1580
9. Farhy LS, Straume M, Johnson ML, Kovatchev BP, Veldhuis JD 2001 A construct of interactive feedback control of the GH axis in the male. Am J Physiol 281:R38-R51
10. Farhy LS, Straume M, Johnson ML, Kovatchev B, Veldhuis JD 2002 Unequal autonegative feedback by GH models the sexual dimorphism in GH secretory dynamics. Am J Physiol 282:R753-R764
11. Farhy LS, Veldhuis JD 2003 Joint pituitary-hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion. Am J Physiol Regul Integr Comp Physiol 285:R1240-R1249
12. Farhy LS, Veldhuis JD 2004 Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator. Am J Physiol 286:R1030-R1042
13. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit J-M 2000 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464
14. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
15. Bowers CY 2000 New insight into the control of growth hormone secretion. In: Kleinberg DL, Clemmons DR, eds. Central and peripheral mechanisms in pituitary disease. Bristol, UK: BioScientifica Ltd; 163-175
16. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K 2001 A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552
17. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
18. Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I 2002 Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429-1436
19. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
20. Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A 2005 Physiology of ghrelin and related peptides. Domest Anim Endocrinol 29:111-144
21. Farhy LS, Veldhuis JD 2005 Deterministic construct of amplifying actions of ghrelin on pulsatile GH secretion. Am J Physiol Regul Integr Comp 288:R1649-R1663
22. Tannenbaum GS, Epelbaum J, Bowers CY 2003 Interrelationship between the novel peptide ghrelin, somatostatin and growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144:967-974
23. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K 2001 Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483-R1487
24. Fairhall KM, Mynett A, Robinson IC 1995 Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144:555-560
25. Bluet-Pajot MT, Epelbaum J, Gourdji D, Hammond C, Kordon C 1998 Hypothalamic and hypophyseal regulation of growth hormone secretion. Cell Mol Neurobiol 18:101-123
26. Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E 2002 The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf) 56:643-648
27. Veldhuis JD, Bowers CY 2003 Three-peptide control of pulsatile and entropic feedback-sensitive modes of growth hormone secretion: modulation by estrogen and aromatizable androgen. J Pediatr Endocrinol Metab 16(Suppl 3):587-605
28. Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Ghigo E 1998 Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1:51-58
29. Cunningham BC, Wells JA 1991 Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88:3407-3411
30. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
31. Horvat S, Medrano JF 2001 Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72:209-212
32. Hochberg Z, Bick T, Amit T 1994 Stoichiometry of the pulsating growth hormone (GH) binding to the GH-binding protein and the turnover GH-receptor. Exp Biol Med 206:249-253
33. Fisker S, Kristensen K, Rosenfalck AM, Pedersen SB, Ebdrup L, Richelsen B, Hilsted J, Christiansen JS, Jorgensen JO 2001 Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact ofGHtreatment. J Clin Endocrinol Metab 86:792-796
34. Takahashi Y, Chihara K 1999 Short stature by mutant growth hormones. Growth Horm IGF Res 9(Suppl B):37-40
35. Rosengren L, Simko H, Aryan L, Axelsson-Lendin P, Chmielewska J, Mode A, Parrow V 2005 Antisense and senseRNA probe hybridization to immobilized crude cellular lysates: a tool to screen growth hormone antagonists. J Biomol Screen 10:260-269
36. Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA 1999 Inhibitory effect of a growth hormone receptor antagonist (G120KPEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 48:377-382
37. Veldhuis JD, Bidlingmaier M, Anderson SM, Evans WS, Wu Z, Strassburger CJ 2002 Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men. J Clin Endocrinol Metab 87:5737-5745
38. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strassburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177
39. Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strassburger CJ 2001 Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men. J Clin Endocrinol Metab 86:3304-3310
40. Dagnaes-Hansen F, Duan H, Rasmussen LM, Friend KE, Flyvbjerg A 2004 Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice. Anticancer Res 24:3735-3742
41. Baumann G 2001 Growth hormone binding protein 2001. J Pediatr Endocrinol Metab 14:355-375
42. Juul A, Fisker S, Scheike T, Hertel T, Muller J, Orskov H, Skakkebaek NE 2000 Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids. Clin Endocrinol (Oxf) 52:165-172
43. Laron Z 2004 Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J Clin Endocrinol Metab 89:1031-1044
44. Wilton P 1992 Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Acta Paediatr Suppl 383:137-141
45. Vaccarello MA, Diamond Jr FB, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab 77:273-280
46. Gluckman PD, Gunn AJ, Wray A, Cutfield WS, Chatelain PG, Guilbaud O, Ambler GR, Wilton P, Albertsson-Wikland K 1992 Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr 121:920-923
47. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288
48. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186
49. Zaina S, Squire S 1998 The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGFII-independent mechanisms. J Biol Chem 273:28610-28616
50. Bajoria R, Sooranna SR, Ward S, Hancock M 2002 Placenta as a link between amino acids, insulin-IGF axis, and low birth weight: evidence from twin studies. J Clin Endocrinol Metab 87:308-315
51. Baxter RC 2000 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol 278:E967-E976
52. Munns CF, Glass IA, Flanagan S, Hayes M, Williams B, Berry M, Vickers D, O'Rourke P, Rao E, Rappold GA, Hyland VJ, Batch JA 2003 Familial growth and skeletal features associated with SHOX haploinsufficiency. J Pediatr Endocrinol Metab 16:987-996
53. Brungger M, Hulter HN, Krapf R 1997 Effect of chronic metabolic acidosis on the growth hormone/IGF-I endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int 51:216-221
54. Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ 1996 Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 24:1460-1466
55. Bjarnason R, Wickelgren R, Hermansson M, Hammarqvist F, Carlsson B, Carlsson LM 1998 Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery. J Clin Endocrinol Metab 83:1566-1572
56. Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H 1999 Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 56:2076-2084
57. Young SC, Underwood LE, Celniker A, Clemmons DR 1992 Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab 75:603-608
58. Veldhuis JD, Iranmanesh A, Wilkowski MJ, Samojlik E 1994 Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men. Eur J Endocrinol 131:489-498
59. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulinlike growth factors in embryonic and postnatal growth. Cell 75:73-82
60. LeRoith D, Werner H, Deitner-Johnson D, Roberts CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
61. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816
62. Ernst M, Rodan GA 1991 Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081-1089
63. Cara JF 1994 Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 42:49-54
64. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA 1993 Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 132:23-29
65. Cardona G, Chowen JA, Garcia-Segura LM 2000 Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J Neurobiol 43:269-281
66. Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO 2000 Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 85:1407-1411
67. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM 2005 Homozygous and heterozygous expression of a novel IGF-I mutation. J Clin Endocrinol Metab 90:2855-2864
68. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
69. Sjogren K, Liu J-L, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OGP, Jansson J-O, Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092
70. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D 2001 Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118
71. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, Boisclair YR 2000 Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci USA 97:6868-6873
72. Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA 1990 Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGFbinding proteins in the rat heart. Endocrinology 127:497-499
73. Silha JV, Gui Y, Modric T, Suwanichkul A, Durham SK, Powell DR, Murphy LJ 2001 Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice. Endocrinology 142:4305-4313
74. DeChiara TM, Robertson EJ, Efstratiadis A 1991 Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859
75. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96:2065-2070
76. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
77. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-2222
78. Kawashima Y, Kanzaki S, Yang F, Kinoshita T, Hanaki K, Nagaishi J, Ohtsuka Y, Hisatome I, Ninomoya H, Nanba E, Fukushima T, Takahashi S 2005 Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. J Clin Endocrinol Metab 90:4679-4687
79. Bailey RC 1991 The comparative growth of Efe pygmies and African farmers from birth to age 5 years. Ann Hum Biol 18:113-120
80. Hattori Y, Vera JC, Rivas CI, Bersch N, Bailey RC, Geffner ME, Golde DW 1996 Decreased insulin-like growth factor I receptor expression and function in immortalized African Pygmy T cells. J Clin Endocrinol Metab 81:2257-2263
81. Nandi A, Kitamura Y, Kahn CR, Accili D 2004 Mouse models of insulin resistance. Physiol Rev 84:623-647
82. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI 1993 Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 5:71-73
83. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR 2000 Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125
84. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A 1996 Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517-535
85. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D 2004 Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114:214-223
86. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF 2000 IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377-382
87. Growth Hormone Research Society 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990-3993
88. Pazos F, Sanchez-Franco F, Balsa J, Lopez-Fernandez J, Escalada J, Cacicedo L 1999 Regulation of gonadal and somatotropic axis by chronic intraventricular infusion of insulin-like growth factor 1 antibody at the initiation of puberty in male rats. Neuroendocrinol 69:408-416
89. Hiney JK, Srivastava V, Nyberg CL, Ojeda SR, Dees WL 1996 Insulin-like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 137:3717-3728
90. Wilson ME 1995 IGF-I administration advances the decrease in hypersensitivity to oestradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. J Endocrinol 145:121-130
91. Melcangi RC, Cavarretta I, Magnaghi V, Martini L, Galbiati M 2001 Interactions between growth factors and steroids in the control of LHRH-secreting neurons. Brain Res Rev 37:223-234
92. Hashizume T, Kumahara A, Fujino M, Okada K 2002 Insulin-like growth factor I enhances gonadotropin-releasing hormone-stimulated luteinizing hormone release from bovine anterior pituitary cells. Anim Reprod Sci 70:13-21
93. Xia YX, Weiss JM, Polack S, Diedrich K, Ortmann O 2001 Interactions of insulin-like growth factor-I, insulin and estradiol with GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol 144:73-79
94. Natesampillai S, Veldhuis JD 2004 Actions of insulin and IGF-I on sterol-metabolizing gene expression in ovarian cells. In: Leung P, Adashi E, eds. The ovary. Boston: Elsevier Press; 249-259
95. Kadakia R, Arraztoa JA, Bondy C, Zhou J 2001 Granulosa cell proliferation is impaired in the Igf1 null ovary. Growth Horm IGF Res 11:220-224
96. Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL 2000 Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85:1686-1694
97. Laron Z, Klinger B 1998 Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol 138:176-180
98. Kuromaru R, Kohno H, Ueyama N, Hassan HM, Honda S, Hara T 1998 Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab 83:3890-3896
99. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulinlike growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
100. Huang Y, Kim SO, Yang N, Jiang J, Frank SJ 2004 Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol 18:1471-1485
101. Porksen N, Hussain MA, Bianda TL, Nyholm B, Christiansen JS, Butler PC, Veldhuis JD, Foresch ER, Schmitz O 1997 IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates. Am J Physiol 272:E352-E358
102. Bagi CM, DeLeon E, Brommage R, Rosen D, Sommer A 1995 Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck. Calcif Tissue Int 57:40-46
103. Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J, Vanderschueren D, Geusens P 2002 Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 87:1593-1599
104. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J 2000 The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85:1518-1524
105. Veldhuis JD, Frystyk J, Iranmanesh A, Orskov H 2005 Testosterone and estradiol regulate free IGF-I, IGFBP-I and dimeric IGF-I/IGFBP-I concentrations. J Clin Endocrinol Metab 90:2941-2947
106. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM, Russell D 1994 Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 135:1913-1920
107. Costello M, Baxter RC, Scott CD 1999 Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 84:611-617
108. Swolin D, Brantsing C, Matejka G, Ohlsson C 1996 Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol 149:397-403
109. Gori F, Hofbauer LC, Conover CA, Khosla S 1999 Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 140:5579-5586
110. Feldman M, Ruan W, Tappin I, Wieczorek R, Kleinberg DL 1999 The effect of GH on estrogen receptor expression in the rat mammary gland. J Endocrinol 163:515-522
111. Leung KC, Johannsson G, Leong GM, Ho KK 2004 Estrogen regulation of growth hormone action. Endocr Rev 25:693-721
112. Anderson LA, McTernan PG, Barnett AH, Kumar S 2001 The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab 86:5045-5051
113. Moller N, Schmitz O, Porksen N, Moller J, Jorgensen JO 1992 Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 41:172-175
114. Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P 1998 A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 83:353-357
115. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
116. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L 1998 Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 49:803-809
117. Deng HW, Li J, Li JL, Dowd R, Davies KM, Johnson M, Gong G, Deng H, Recker RR 2000 Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 85:2748-2751
118. Kimm SY, Glynn NW, Aston CE, Damcott CM, Poehlman ET, Daniels SR, Ferrell RE 2002 Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr 75:714-719
119. Ahmed SF, Hughes IA 2002 The genetics of male undermasculinization. Clin Endocrinol (Oxf) 56:1-18
120. Veldhuis JD 1999 Male hypothalamic-pituitary-gonadal axis. In: Yen SSC, Jaffe RB, Barbieri RL, eds. Reproductive endocrinology. Philadelphia: W. B. Saunders Co.; 622-631
121. Huhtaniemi I, Pelliniemi LJ 1992 Fetal Leydig cells: cellular origin, morphology, life span, and special functional features. Proc Soc Exp Biol Med 201:125-140
122. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, van Reen M, Milgrom E, Ropers H-H, Mariman E, Themmen APN, Brunner HG 1995 Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-164
123. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736
124. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I 2001 Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:172-183
125. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF 2000 Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 85:4013-4018
126. Ross AJ, Capel B 2005 Signaling at the crossroads of gonad development. Trends Endocrinol Metab 16:19-25
127. Blumenfeld Z, Ritter M 2001 Inhibin, activin, and follistatin in human fetal pituitary and gonadal physiology. Ann NY Acad Sci 943:34-48
128. Tan K, De Gendt K, Atanassova N, Walker M, Sharpe RM, Saunders P, Denolet E, Verhoeven G 2005 The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total (ARKO) or Sertoli cell-selective (SCARKO) ablation of the androgen receptor. Endocrinology 146:2674-2683
129. Ge RS, Dong Q, Sottas CM, Chen H, Zirkin BR, Hardy MP 2005 Gene expression in rat Leydig cells during development from the progenitor to adult stage: a cluster analysis. Biol Reprod 72:1405-1415
130. Lin T, Wang D, Hu J, Stocco DM 1998 Upregulation of human chorionic gonadotrophin-induced steroidogenic acute regulatory protein by insulin-like growth factor-I in rat Leydig cells. Endocrine 8:73-78
131. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, Hales DB, Miller WL, Culty M, Papadopoulos V 2005 Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol Endocrinol 19:540-554
132. Abney TO 1999 The potential roles of estrogens in regulating Leydig cell development and function: a review. Steroids 64:610-617
133. Wu X, Arumugam R, Baker SP, Lee MM 2004 Pubertal and adult Leydig cell function in Mullerian inhibiting substance (MIS/AMH) deficient mice. Endocrinology 146:589-595
134. Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, Morel Y, Chaussain JL 2002 Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 87:29-32
135. Plant TM 1985 A study of the role of the postnatal testes in determining the ontogeny of gonadotropin secretion in the male rhesus monkey (Macaca mulatta). Endocrinology 116:1341-1350
136. Corbier P, Dehennin L, Castanier M, Mebazaa A, Edwards DA, Roffi J 1990 Sex differences in serum luteinizing hormone and testosterone in the human neonate during the first few hours after birth. J Clin Endocrinol Metab 71:1344-1348
137. de Zegher F, Devlieger H, Veldhuis JD 1992 Pulsatile and sexually dimorphic secretion of luteinizing hormone in the human infant on the day of birth. Pediatr Res 32:605-607
138. Parker KL, Schimmer BP 1997 Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 18:361-377
139. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P 1997 DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390:311-315
140. Lin D, Sugawara A, Strauss JFI, Clark BJ, Stocco DM, Saenger P, Rogol AD, Miller WL 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828-1831
141. Palmert MR, Hayden DL, Mansfield MJ, Crigler JF, Crowley Jr WF, Chandler DW, Boepple PA 2001 The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 86:4536-4542
142. Sklar CA, Kaplan SL, Grumbach MM 1980 Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 51:548-556
143. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD 1993 Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505-1510
144. Dardis A, Saraco N, Rivarola MA, Belgorosky A 1999 Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: implications for the mechanism of adrenarche. Pediatr Res 45:384-388
145. Voutetakis A, Livadas S, Sertedaki A, Maniati-Christidi M, Dacou-Voutetakis C 2001 Insufficient adrenarche in patients with combined pituitary hormone deficiency caused by a PROP-1 gene defect. J Pediatr Endocrinol 14:1107-1111
146. Kaplowitz PB, Oberfield SE 1999 Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 104:936-941
147. Vuguin P, Linder B, Rosenfeld RG, Saenger P, DiMartino-Nardi J 1999 The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab 84:2037-2042
148. Ibanez L, Potau N, Enriquez G, de Zegher F 2000 Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res 47:575-577
149. Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE 2002 Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab 87:398-403
150. Arslanian SA, Lewy V, Danadian K, Saad R 2002 Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 87:1555-1559
151. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
152. Ibanez L, Ong K, Potau N, Marcos MV, de Zegher F, Dunger D 2001 Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence. J Clin Endocrinol Metab 86:5788-5793
153. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y 2001 Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 86:446-449
154. Mesiano S, Katz SL, Lee JY, Jaffe RB 1997 Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J Clin Endocrinol Metab 82:1390-1396
155. Zhang G, Garmey JC, Veldhuis JD 2000 Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17 α-hydroxylase/17, 20-lyase (CYP17) genes in porcine theca cells. Endocrinology 141:2735-2742
156. Veldhuis JD, Zhang G, Garmey JC 2002 Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro. J Clin Endocrinol Metab 87:1129-1133
157. Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M 1998 Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome. Eur J Endocrinol 139:621-630
158. Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M 2000 Disruption of the joint synchrony of luteinizing hormone, testosterone and androstenedione secretion in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:72-79
159. Kero J, Poutanen M, Zhang F-P, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 105:633-641
160. Urban RJ, Evans WS, Rogol AD, Kaiser DL, Johnson ML, Veldhuis JD 1988 Contemporary aspects of discrete peak detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev 9:3-37
161. Veldhuis JD, Pincus SM, Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A 2001 Developmentally delimited emergence of more orderly luteinizing hormone and testosterone secretion in late prepuberty in boys. J Clin Endocrinol Metab 86:80-89
162. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler Jr GB 1994 Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94:2475-2480
163. Clark PA, Iranmanesh A, Veldhuis JD, Rogol AD 1997 Comparison of pulsatile luteinizing hormone secretion between prepubertal children and young adults: evidence for a mass/amplitudedependent difference without gender or day/night contrasts. J Clin Endocrinol Metab 82:2950-2955
164. Wu FCW, Butler GE, Kelnar CJH, Huhtaniemi I, Veldhuis JD 1996 Patterns of pulsatile luteinizing hormone secretion from childhood to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J Clin Endocrinol Metab 81:1798-1805
165. Evans WS, Sollenberger MJ, Booth Jr RA, Rogol AD, Urban RJ, Carlsen EC, Johnson ML, Veldhuis JD 1992 Contemporary aspects of discrete peak detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev 13:81-104
166. Terasawa E, Fernandez DL 2001 Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 22:111-151
167. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley Jr WF, Aparicio SA, Colledge WH 2003 The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627
168. Gottsch ML, Cunningham MJ, Smith JT, Popa SM, Acohido BV, Crowley WF, Seminara S, Clifton DK, Steiner RA 2004 A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145:4073-4077
169. De Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972-10976
170. Navarro VM, Castellano JM, Fernandez-Fernandez R, Tovar S, Roa J, Mayen A, Nogueiras R, Vazquez MJ, Barreiro ML, Magni P, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M 2005 Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 146:156-163
171. Navarro VM, Castellano JM, Fernandez-Fernandez R, Barreiro ML, Roa J, Sanchez-Criado JE, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M 2004 Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 145:4565-4574
172. Castellano JM, Navarro VM, Fernandez-Fernandez R, Nogueiras R, Tovar S, Roa J, Vazquez MJ, Vigo E, Casanueva FF, Aguilar E, Pinilla L, Dieguez C, Tena-Sempere M 2005 Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146:3917-3925
173. Schwanzel-Fukuda M, Crossin KL, Pfaff DW, Bouloux PM, Hardelin JP, Petit C 1996 Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J Comp Neurol 366:547-557
174. Mason A, Hayflick JC, Zoeller RT 1986 A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366-1371
175. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P 1991 A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529-536
176. Georgopoulos NA, Pralong FP, Seidman CE, Seidman JG, Crowley Jr WF, Vallejo M 1997 Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 82:213-217
177. Waldstreicher J, Seminara SB, Jameson JL, Geyer A, Nachtigall LB, Boepple PA, Holmes LB, Crowley Jr WF 1996 The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 81:4388-4395
178. Seminara SB, Boepple PA, Nachtigall LB, Pralong FP, Khoury RH, Sluss PM, Lecain AE, Crowley Jr WF 1996 Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after short term physiologic GnRH replacement - a clinical research center study. J Clin Endocrinol Metab 81:3692-3696
179. Albuisson J, Pecheux C, Carel JC, LaCombe D, Leheup B, Lapuzina P, Bouchard P, Legius E, Matthijs G, Wasniewska M, Delpech M, Young J, Hardelin JP, Dode C 2005 Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat 25:98-99
180. Oliveira LM, Seminara SB, Beranova M, Hayes FJ, Valkenburgh SB, Schipani E, Costa EM, Latronico Ac, Crowley Jr WF, Vallejo M2001 The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 86:1532-1538
181. Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD 1998 Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 18:14-15
182. Dubois EA, Zandbergen MA, Peute J, Goos HJ 2002 Evolutionary development of three gonadotropin-releasing hormone (GnRH) systems in vertebrates. Brain Res Bull 57:413-418
183. Latimer VS, Kohama SG, Garyfallou VT, Urbanski HF 2001 A developmental increase in the expression of messenger ribonucleic acid encoding a second form of gonadotropin-releasing hormone in the rhesus macaque hypothalamus. J Clin Endocrinol Metab 86:324-329
184. Urbanski HF, White RB, Fernald RD, Kohama SG, Garyfallou VT, Densmore VS 1999 Regional expression of mRNA encoding a second form of gonadotropin- releasing hormone in the macaque brain. Endocrinology 140:1945-1948
185. Kang SK, Tai CJ, Nathwani PS, Leung PCK 2001 Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 142:182-192
186. Densmore VS, Urbanski HF 2003 Relative effect of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on gonadotropin release. J Clin Endocrinol Metab 88:2126-2134
187. Millar R, Lowe S, Conklin D, Pawson A, Maudsley S, Troskie B, Ott T, Millar M, Lincoln G, Sellar R, Faurholm B, Scobie G, Kuestner R, Terasawa E, Katz A 2001 Anovel mammalian receptor for the evolutionarily conserved type II GnRH. Proc Natl Acad Sci USA 98:9636-9641
188. Barnett DK, Bunnell TM, Millar RP, Abbott DH 2006 Gonadotropin-releasing hormone II stimulates female sexual behavior in marmoset monkeys. Endocrinology 147:615-623
189. Ahmed SF, Cheng A, Dovey L, Hawkins JR, Martin H, Rowland J, Shimura N, Tait AD, Hughes IA 2000 Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 85:658-665
190. Hosoda A, Fujieda K, Matsuura N, Okuno A, Yuri K 1991 Age-related change of pulsatile gonadotropin secretion in Turner syndrome. Pediatr Res 29:196-200
191. Cemeroglu AP, Foster CM, Warner R, Kletter GB, Marshall JC, Kelch RP 1996 Comparison of the neuroendocrine control of pubertal maturation in girls and boys with spontaneous puberty and hypogonadal girls. J Clin Endocrinol Metab 81:4352-4357
192. Rapisarda JJ, Bergman KS, Steiner RA, Foster DL 1983 Response to estradiol inhibition of tonic luteinizing hormone secretion decreases during the final stage of puberty in the rhesus monkey. Endocrinology 112:1172-1179
193. Witkin JW, Ferin M, Popilskis SJ, Silverman AJ 1991 Effects of gonadal steroids on the ultrastructure of GnRH neurons in the rhesus monkey: synaptic input and glial apposition. Endocrinology 120:1803-1892
194. Herbison AE 1998 Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 19:302-330
195. Scott CJ, Kuehl DE, Ferreira SA, Jackson GL 1997 Hypothalamic sites of action for testosterone, dihydrotestosterone, and estrogen in the regulation of luteinizing hormone secretion in male sheep. Endocrinology 138:3686-3694
196. Ogawa S, Washburn TF, Taylor J, Lubahn DB, Korach KS, Pfaff DW 1998 Modifications of testosterone-dependent behaviors by estrogen receptor-α gene disruption in male mice. Endocrinology 139:5058-5069
197. Ogawa S, Chan J, Chester AE, Gustafsson JA, Korach KS, Pfaff DW 1999 Survival of reproductive behaviors in estrogen receptor β gene-deficient (βERKO) male and female mice. Proc Natl Acad Sci USA 96:12887-12892
198. Skynner MJ, Sim JA, Herbison AE 1999 Detection of estrogen receptor α and β messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 140:5195-5201
199. Lephart ED 1996 A review of brain aromatase cytochrome P450. Brain Res Brain Res Rev 22:1-26
200. Chen Z, Zheng H, Dong KW 2001 Identification of negative and positive estrogen response elements in human GnRH upstream promoter in the placental JEG-3 cells. Mol Cell Endocrinol 184:125-134
201. Curtin D, Jenkins S, Farmer N, Anderson AC, Haisenleder DJ, Rissman E, Wilson EM, Shupnik MA 2001 Androgen suppression of GnRH-stimulated rat LH β gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Mol Endocrinol 15:1906-1917
202. Wersinger SR, Haisenleder DJ, Lubahn DB, Rissman EF 1999 Steroid feedback on gonadotropin release and pituitary gonadotropin subunit mRNA in mice lacking a functional estrogen receptor α. Endocrine 11:137-143
203. Auger AP, Tetel MJ, McCarthy MM 2000 Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc Natl Acad Sci USA 97:7551-7555
204. Wickman S, Dunkel L 2001 Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E. J Clin Endocrinol Metab 86:4887-4894
205. Schnorr JA, Bray MJ, Veldhuis JD 2001 Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous GnRH-stimulated LH and FSH secretion in young men. J Clin Endocrinol Metab 86:2600-2606
206. Kasuya E, Nyberg CL, Mogi K, Terasawa E 1999 A role of γ-amino butyric acid (GABA) and glutamate in control of puberty in female rhesus monkeys: effect of an antisense oligodeoxynucleotide for GAD67 messenger ribonucleic acid and MK801 on luteinizing hormone-releasing hormone release. Endocrinology 140:705-712
207. Ferreira SA, Scott CJ, Kuehl De, Jackson GL 1996 Differential regulation of luteinizing hormone release by γ-aminobutyric acid receptor subtypes in the arcuate-ventromedial region of the castrated ram. Endocrinology 137:3453-3460
208. Mitsushima D, Hei DL, Terasawa E 1994 γ-Aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci USA 91:395-399
209. Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML 1999 Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology 140:4046-4055
210. El Majdoubi M, Sahu A, Ramaswamy S, Plant TM 2000 Neuropeptide Y: a hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci USA 97:6179-6184
211. Medhamurthy R, Dichek HL, Plant TM, Bernardini I, Cutler GBJ 1990 Stimulation of gonadotropin secretion in prepubertal monkeys after hypothalamic excitation with aspartate and glutamate. J Clin Endocrinol Metab 71:1390-1392
212. Bourguignon JP, Gerard A, Alvarez Gonzalez ML, Franchimont P 1992 Neuroendocrine mechanism of onset of puberty. Sequential reduction in activity of inhibitory and facilitatory N-methyl-daspartate receptors. J Clin Invest 90:1736-1744
213. Bourguignon JP, Jaeken J, Gerard A, de Zegher F 1997 Amino acid neurotransmission and initiation of puberty: evidence from nonketotic hyperglycinemia in a female infant and gonadotropin-releasing hormone secretion by rat hypothalamic explants. J Clin Endocrinol Metab 82:1899-1903
214. Cook JS, Bale JFJ, Hoffman RP 1992 Pubertal arrest associated with valproic acid therapy. Pediatr Neurol 8:229-231
215. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV 1993 Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:1383-1388
216. Veldhuis JD, Kulin HE, Warner BA, Santner SJ 1982 Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals. J Clin Endocrinol Metab 55:649-653
217. Hileman SM, Lubbers LS, Petersen SL, Kuehl DE, Scott CJ, Jackson GL 1996 Influence of testosterone on LHRH release, LHRH mRNA and proopiomelanocortin mRNA in male sheep. J Neuroendocrinol 8:113-121
218. Gonzalez MI, Baker BI, Wilson CA 1997 Stimulatory effect of melanin-concentrating hormone on luteinising hormone release. Neuroendocrinol 66:254-262
219. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS 1997 Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 99:391-395
220. Murahashi K, Bucholtz DC, Nagatani S, Tsukahara S, Tsukamura H, Foster DL, Maeda KI 1996 Suppression of luteinizing hormone pulses by restriction of glucose availability is mediated by sensors in the brain stem. Endocrinology 137:1171-1176
221. Gallo F, Morale MC, Tirolo C, Testa N, Farinella Z, Avola R, Beaudet A, Marchetti B 2000 Basic fibroblast growth factor priming increases the responsiveness of immortalized hypothalamic luteinizing hormone releasing hormone neurones to neurotrophic factors. J Neuroendocrinol 12:941-959
222. Evans JJ 1999 Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland. Endocr Rev 20:46-67
223. Legro RS, Lin HM, Demers LM, Lloyd T 2000 Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab 85:1021-1025
224. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC 1998 Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83:582-590
225. Imperato-McGinley J 1997 5 α-Reductase-2 deficiency. Curr Ther Endocrinol Metab 6:384-387
226. Wisniewski AB, Migeon CJ 2002 Long-term perspectives for 46,XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. Semin Reprod Med 20:297-304
227. Carani C, Rochira V, Faustini-Fustini M, Balestrieri A, Granata AR 1999 Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol (Oxf) 51:517-524
228. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS 1999 Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100
229. Chen MD, Ordog T, O'Byrne KT, Goldsmith JR, Connaughton MA, Knobil E 1996 The insulin hypoglycemia-induced inhibition of gonadotropin-releasing hormone pulse generator activity in the rhesus monkey: role of vasopressin and corticotropin-releasing factor. Endocrinology 137:2012-2021
230. Bergendahl M, Veldhuis JD 1995 Altered pulsatile gonadotropin signaling in nutritional deficiency in the male. Trends Endocrinol Metab 6:145-159
231. Veldhuis JD, Yoshida K, Iranmanesh A 1998 The effect of mental and metabolic stress on the female reproductive system and female reproductive hormones. In: Hubbard J, Workman EA, eds. Handbook of stress medicine: an organ system approach. Boca Raton, FL: CRC Press; 115-140
232. La Marca A, Morgante G, De Leo V 1999 Evaluation of hypothalamic- pituitary-adrenal axis in amenorrhoeic women with insulindependent diabetes. Hum Reprod 14:298-302
233. Ohkura S, Tanaka T, Nagatani S, Bucholtz DC, Tsukamura H, Maeda K, Foster DL 2000 Central, but not peripheral, glucosesensing mechanisms mediate glucoprivic suppression of pulsatile luteinizing hormone secretion in the sheep. Endocrinology 141:4472-4480
234. Comussie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Kwitek-Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero J, Cohen D 2001 The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86:4321-4325
235. Danilovich N, Wernsing D, Coschigano KT, Kopchick JJ, Bartke A 1999 Deficits in female reproductive function in GH-R-KO mice; role of IGF-I. Endocrinology 140:2637-2640
236. Lado-Abeal J, Hickox JR, Cheung TL, Veldhuis JD, Hardy DM, Norman RL 2000 Neuroendocrine consequences of fasting in adult male macaques: effects of recombinant rhesus macaque leptin infusion. J Neuroendocrinol 71:196-208
237. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307-312
238. Zhang F, Chen Y, Heiman M, Dimarchi R 2005 Leptin: structure, function and biology. Vitam Horm 71:345-372
239. Frisch RE 1972 Weight at menarche: similarity for well-nourished and undernourished girls at differing ages, and evidence for historical constancy. Pediatr 50:445-450
240. Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O'Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, McCann SM, Wong ML 2004 Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 101:4531-4536
241. Matkovic V, Ilich JZ, Skugor M, Badenhop NE, Goel P, Clairmont A, Klisovic D, Nahhas RW, Landoll JD 1997 Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 82:3239-3245
242. Palmert MR, Radovick S, Boepple PA 1998 Leptin levels in children with central precocious puberty. J Clin Endocrinol Metab 83:2260-2265
243. Andreelli F, Hanaire-Broutin H, Laville M, Tauber JP, Riou JP, Thivolet C 2000 Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J Clin Endocrinol Metab 85:715-719
244. Gill MS, Hall CM, Tillmann V, Clayton PE 1999 Constitutional delay in growth and puberty (CDGP) is associated with hypoleptinaemia. Clin Endocrinol (Oxf) 50:721-726
245. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W, Haunter H 1997 Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 100:808-813
246. Roemmich JN, Clark PA, Berr SS, Mai V, Mantzoros CS, Flier JS, Weltman A, Rogol AD 1998 Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am J Physiol 275:E543-E551
247. Matsuda J, Yokota I, Iida M, Murakami T, Naito E, Ito M, Shima K, Kuroda Y 1997 Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 82:1642-1644
248. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT 1997 The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82:1293-1300
249. Bergendahl M, Iranmanesh A, Evans WS, Veldhuis JD 2000 Shortterm fasting selectively suppresses leptin pulse mass and 24-hour rhythmic leptin release in healthy mid-luteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). J Clin Endocrinol Metab 85:207-213
250. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS 2003 The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 111:1409-1421
251. Havel PJ, Townsend R, Chaump L, Teff K 1999 High-fat meals reduce 24-h circulating leptin concentrations in women. Diabetes 48:334-341
252. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM 2001 Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121
253. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M 1999 Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568-1575
254. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL 2002 Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87:2391-2394
255. Plant TM, Durrant AR 1997 Circulating leptin does not appear to provide a signal for triggering the initiation of puberty in the male rhesus monkey (Macaca mulatta). Endocrinology 138:4505-4508
256. Barker-Gibb ML, Sahu A, Pohl CR, Plant TM 2002 Elevating circulating leptin in prepubertal male rhesus monkeys (Macaca mulatta) does not elicit precocious gonadotropin-releasing hormone release, assessed indirectly. J Clin Endocrinol Metab 87:4976-4983
257. Iqbal J, Pompolo S, Considine RV, Clarke IJ 2000 Localization of leptin receptor-like immunoreactivity in the corticotropes, somatotropes, and gonadotropes in the ovine anterior pituitary. Endocrinology 141:1515-1520
258. Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ, Todd JF, Ghatei MA, Small CJ, Bloom SR 2003 Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 144:3943-3949
259. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S 1998 Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76
260. Tena-Sempere M, Pinilla L, Gonzalez LC, Dieguez C, Casanueva FF, Aguilar E 1999 Leptin inhibits testosterone secretion from adult rat testis in vitro. J Endocrinol 161:211-218
261. Zachow RJ, Magoffin DA 1997 Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-1 on follicle-stimulating hormone-dependent estradiol-17 β production by rat ovarian granulosa cells. Endocrinology 138:847-850
262. Agarwal SK, Vogel K, Weitsman SR, Magoffin DA 1999 Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 84:1072-1076
263. Duggal PS, Van Der Hoek KH, Milner CR, Ryan NK, Armstrong DT, Magoffin DA, Norman RJ 2000 The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology 141:1971-1976
264. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
265. Stutz AM, Morrison CD, Argyropoulos G 2005 The Agouti-related protein and its role in energy homeostasis. Peptides 26:1771-1781
266. Seeley RJ, Drazen DL, Clegg DJ 2004 The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr 24:133-149
267. Lall S, Balthasar N, Carmignac D, Magoulas C, Sesay A, Houston P, Mathers K, Robinson I 2004 Physiological studies of transgenic mice overexpressing growth hormone (GH) secretagogue receptor 1A in GH-releasing hormone neurons. Endocrinology 145:1602-1611
268. Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, Dieguez C 2003 Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144:544-551
269. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M 2003 Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144:1506-1512
270. Herzog H 2003 Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480:21-29
271. Larsen PJ, Tang-Christensen M, Stidsen CE, Madsen K, Smith MS, Cameron JL 1999 Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys. J Clin Endocrinol Metab 84:3781-3791
272. Li C, Chen P, Smith MS 1999 Morphological evidence for direct interaction between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-releasing hormone neurons and the possible involvement of NPY Y1 receptors. Endocrinology 140:5382-5390
273. Lawrence CB, Snape AC, Baudoin FM, Luckman SM 2002 Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143:155-162
274. Bluet-Pajot MT, Tolle V, Zizzari P, Robert C,HammondC, Mitchell V, Beauvillain JC, Viollet C, Epelbaum J, Kordon C 2001 Growth hormone secretagogues and hypothalamic networks. Endocrine 14:1-8
275. Suzuki N, Okada K, Minami S, Wakabayashi I 1996 Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus. Regul Pept 65:145-151
276. Barker-Gibb ML, Scott CJ, Boublik JH, Clarke IJ 1995 The role of neuropeptide Y (NPY) in the control ofLHsecretion in the ewe with respect to season, NPY receptor subtype and the site of action in the hypothalamus. J Endocrinol 147:565-579
277. Lebrethon MC, Vandersmissen E, Gerard A, Parent AS, Bourguignon JP 2000 Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat gonadotropin-releasing hormone pulse generator in vitro. J Neuroendocrinol 12:383-385
278. Broberger C 1999 Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res 848:101-113
279. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB, Elmquist JK 2001 Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 432:1-19
280. Tsukamura H, Nagatani S, Cagampang FR, Kawakami S, Maeda K 1994 Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of α-adrenergic receptors in the paraventricular nucleus in female rats. Endocrinology 134:1460-1466
281. Mounier F, Pellegrini E, Kordon C, Epelbaum J, Bluet-Pajot MT 1997 Continuous intracerebroventricular administration of a corticotropin releasing hormone antagonist amplifies spontaneous growth hormone pulses in the rat. J Endocrinol 152:431-436
282. Cardona-Gomez GP, Mendez P, Doncarlos LL, Azcoitia I, Garcia-Segura LM 2002 Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J Steroid Biochem Mol Biol 83:211-217
283. Aloi JA, Bergendahl M, Iranmanesh A, Veldhuis JD 1997 Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal-weight men. J Clin Endocrinol Metab 82:1543-1548
284. Cates PS, O'Byrne KT 2000 The area postrema mediates insulin hypoglycaemia-induced suppression of pulsatile LH secretion in the female rat. Brain Res 853:151-155
285. Howland BE 1979 Effect of underfeeding on the inhibition of gonadotrophin secretion by testosterone propionate in rats. J Reprod Fertil 55:335-338
286. Iqbal J, Kurose Y, Canny B, Clarke IJ 2006 Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 147:510-519
287. Furuta M, Funabashi T, Kimura F 2001 Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem Biophys Res Commun 288:780-785
288. Clarke IJ, Horton BB, Doughton JB 1990 Investigation of the mechanism by which insulin-induced hypoglycemia decreases luteinizing hormone secretion in ovariectomized ewes. Endocrinology 127:1470-1476
289. Bennett PA, Thomas GB, Howard AD, Feighner SD, van der Ploeg LH, Smith RG, Robinson IC 1997 Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138:4552-4557
290. Pellegrini E, Carmignac DF, Bluet-Pajot MT, Mounier F, Bennett P, Epelbaum J, Robinson ICAF 1997 Intrahypothalamic growth hormone feedback: from dwarfism to acromegaly in the rat. Endocrinology 138:4543-4551
291. Pellegrini E, Bluet-Pajot MT, Mounier F, Bennett P, Kordon C, Epelbaum J 1996 Central administration of a growth hormone (GH) receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats. J Neurosci 16:8140-8148
292. Chihara K, Minamitani N, Kaji H, Arimura A, Fujita T 1981 Intraventrically injected growth hormone stimulates somatostatin release into rat hypophyseal portal blood. Endocrinology 109:2279-2281
293. Horvath S, Palkovits M, Gorcs T, Arimura A 1989 Electron microscopic immunocytochemical evidence for the existence of bidirectional synaptic connections between growth hormone-releasing hormone and somatostatin-containing neurons in the hypothalamus of the rat. Brain Res 481:8-15
294. Bertherat J, Dournaud P, Bérod A, Normand E, Bloch B, Rostène W, Kordon C, Epelbaum J 1992 Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: a combined in situ
295. Bertherat J, Timsit J, Bluet-Pajot M-T, Mercadier J-J, Gourdji D, Kordon C, Epelbaum J 1993 Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. J Clin Invest 91:1783-1791
296. Harel Z, Tannenbaum GS 1992 Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Endocrinology 131:758-764
297. Liposits Z, Merchenthaler I, Paull WK, Flerko B 1988 Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat. Histochemistry 89:247-252
298. Smith RG, van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt Jr MJ, Fisher MH, Nargund RP, Patchett AA 1997 Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645
299. Lanneau C, Bluet-Pajot MT, Zizzari P, Csaba Z, Dournaud P, Helboe L, Hoyer D, Pellegrini E, Tannenbaum GS, Epelbaum J, Gardette R 2000 Involvement of the Sst1 somatostatin receptor subtype in the intrahypothalamic neuronal network regulating growth hormone secretion: an in vitro and in vivo antisense study. Endocrinology 141:967-979
300. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Oikawa S 2001 Regulation of the ghrelin gene: growth hormone-releasing hormone upregulates ghrelin mRNA in the pituitary. Endocrinology 142:4154-4157
301. Baumbach WR, Carrick TA, Pausch MH, Bingham B, Carmignac D, Robinson ICAF, Houghten R, Eppler CM, Price LA, Zysk JR 1998 A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol Pharmacol 54:864-873
302. Veldhuis JD, Evans WS, Shah N, Story S, Bray MJ, Anderson SM 1999 Proposed mechanisms of sex-steroid hormone neuromodulation of the human GH-IGF-I axis. In: Veldhuis JD, Giustina A, eds. Sex-steroid interactions with growth hormone. New York: Springer-Verlag; 93-121
303. Waxman DJ, Pampori NA, Ram PA, Agrawal AK, Shapiro BH 1991 Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc Natl Acad Sci USA 88:6868-6872
304. Davey HW, Wilkins RJ, Waxman DJ 1999 STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am J Hum Genet 65:959-965
305. Pincus SM, Gevers E, Robinson ICAF, van den Berg G, Roelfsema F, Hartman ML, Veldhuis JD 1996 Females secrete growth hormone with more process irregularity than males in both human and rat. Am J Physiol 270:E107-E115
306. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B 1992 Importance of growth hormone for the function of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89:6983-6987
307. Al Hendy A, Hortelano G, Tannenbaum GS, Chang PL 1996 Growth retardation-an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum Gene Ther 7:61-70
308. Draghia-Akli R, Malone PB, Hill LA, Ellis KM, Schwartz RJ, Nordstrom JL 2002 Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J 16:426-428
309. Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD 2001 Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1,44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. J Clin Endocrinol Metab 86:700-712
310. Lahuna O, Fernandez L, Karlsson H, Maiter D, Lemaigre FP, Rousseau GG, Gustafsson J, Mode A 1997 Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proc Natl Acad Sci USA 94:12309-12313
311. Sueyoshi T, Yokomori N, Korach KS, Negishi M 1999 Developmental action of estrogen receptor-α feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp2d9 genes in mouse liver. Mol Pharmacol 56:473-477
312. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG 2003 Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349:1139-1147
313. Hindmarsh PC, Fall CH, Pringle PJ, Osmond C, Brook CG 1997 Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters. J Clin Endocrinol Metab 82:2172-2176
314. DiMartino-Nardi J, Wu R, Fishman K, Saenger P 1991 The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J Clin Endocrinol Metab 73:902-906
315. Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samojlik E, Hintz RL, Veldhuis JD 1999 Androgenic modulation of the growth hormone-IGF axis and its impact on metabolic outcomes. In: Veldhuis JD, Giustina A, eds. Sex-steroid interaction with growth hormone. New York: Springer-Verlag New York, Inc.; 82-92
316. Veldhuis JD, Roemmich JN, Rogol AD 2000 Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females-a general clinical research center-based study. J Clin Endocrinol Metab 85:2385-2394
317. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD 1994 Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94:1277-1288
318. Moller N, Jorgensen JO, Schmitz O, Moller J, Christiansen J, Alberti KG, Orskov H 1990 Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 258:E86-E91
319. Jorgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS 1991 Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 72:582-587
320. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ 1999 Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785-792
321. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD 1998 Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur J Endocrinol 139:59-71
322. Balthasar N, Mery PF, Magoulas CB, Mathers KE, Martin A, Mollard P, Robinson IC 2003 Growth hormone-releasing hormone (GHRH) neurons in GHRH-enhanced green fluorescent protein transgenic mice: a ventral hypothalamic network. Endocrinology 144:2728-2740
323. Frohman LA, Kineman RD, Kamegai J, Park S, Teixeira LT, Coschigano KT, Kopchic JJ 2000 Secretagogues and the somatotrope: signaling and proliferation. Rec Prog Horm Res 55:269-290
324. Aleppo G, Moskal SF, De Grandis PA, Kineman RD, Frohman LA 1997 Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels. Endocrinology 138:1058-1065
325. Magnan E, Cataldi M, Guillaume V, Conte-Devolx B, Graziani N, Figaroli JC, Thomas F, Chihara K, Oliver C 1992 Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Sci 51:831-838
326. Hindmarsh PC, Brain CE, Robinson ICAF, Matthews DR, Brook CG 1991 The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clin Endocrinol (Oxf) 35:353-360
327. Veldhuis JD, Evans WS, Bowers CY 2002 Impact of estradiol supplementation on dual peptidyl drive of growth-hormone secretion in postmenopausal women. J Clin Endocrinol Metab 87:859-866
328. Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ 1991 Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology 128:1151-1158
329. Veldhuis JD, Fletcher TP, Gatford KL, Egan AR, Clarke IJ 2002 Hypophyseal-portal somatostatin (SIRF) and jugular venous growth hormone secretion in the conscious unrestrained ewe. Neuroendocrinology 75:83-91
330. Bowers CY, Chang J, Momany F, Folkers K 1977 Effect of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. In: MacIntyre I, Szelke M, eds. Molecular endocrinology. Amsterdam: Elsevier/North Holland; 287-292
331. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
332. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strassburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
333. Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981
334. Sun Y, Wang P, Zheng H, Smith RG 2004 Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101:4679-4684
335. De Smet B, Depoortere I, Moechars D, Swennen Q, Moreaux B, Cryns K, Tack J, Buyse J, Coulie B, Peeters T 2005 Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 316:431-439
336. Zizzari P, Halem H, Taylor J, Dong JZ, Datta R, Culler MD, Epelbaum J, Bluet-Pajot MT 2005 Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146:3836-3842
337. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M 2005 Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54:18-24
338. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M 2000 Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275:477-480
339. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037
340. Thompson NM, Gill DAS, Davies R, Loveridge N, Houston PA, Robinson ICAF, Wells T 2004 Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145:234-242
341. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J 2002 Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146:241-244
342. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K 2001 Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86:4753-4758
343. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630
344. Broglio F, Koetsveld PP, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Gauna C, Hofland L, Deghenghi R, Arvat E, van der Lely AJ, Ghigo E 2002 Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 87:4829-4832
345. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M 2002 The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128
346. Hinney A, Hoch A, Geller F, Schafer H, Siegfried W, Goldschmidt H, Remschmidt H, Hebebrand J 2002 Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 87:2716
347. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, Bouchard C 2001 Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86:3996-3999
348. Wang HJ, Geller F, Dempfle A, Schauble N, Friedel S, Lichtner P, Fontenla-Horro F, Wudy S, Hagemann S, Gortner L, Huse K, Remschmidt H, Bettecken T, Meitinger T, Schafer H, Hebebrand J, Hinney A 2004 Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 89:157-162
349. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076
350. Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD 2004 Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women. J Clin Endocrinol Metab 89:2290-2300
351. Shah N, Evans WS, Bowers CY, Veldhuis JD 1999 Tripartite neuroendocrine activation of the human growth-hormone (GH) axis in women by continuous 24-hour GH-releasing peptide (GHRP-2) infusion: pulsatile, entropic, and nyctohemeral mechanisms. J Clin Endocrinol Metab 84:2140-2150
352. Svensson J, Lonn L, Jansson J-O, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjostrom L, Bengtsson BA 1998 Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab 83:362-369
353. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Verbruggen W, Awouters M, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY 1997 The somatotropic axis in critical illness: effects of continuous GHRH and GHRP-2 infusion. J Clin Endocrinol Metab 82:590-599
354. Murphy MG, Plunkett LM, Gertz BJ, He W, Wittreich J, Polvino WM, Clemmons DR 1998 MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab 83:320-325
355. Pihoker C, Badger TM, Reynolds GA, Bowers CY 1997 Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J Endocrinol 155:79-86
356. Codner E, Cassorla F, Tiulpakov AN, Mericq MV, Avila A, Pescovitz OH, Svensson J, Cerchio K, Krupa D, Gertz BJ, Murphy G 2001 Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormoneinsulin-like growth factor I axis in growth hormone-deficient children. Clin Pharmacol Ther 70:91-98
357. Mericq V, Cassorla F, Salazar T, Avila A, Iniguez G, Bowers CY, Merriam GR 1998 Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J Clin Endocrinol Metab 83:2355-2360
358. Klinger B, Silbergeld A, Deghenghi R, Frenkel J, Laron Z 1996 Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. Eur J Endocrinol 134:716-719
359. Laron Z, Frenkel J, Deghenghi R, Anin S, Klinger B, Silbergeld A1995 Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin Endocrinol (Oxf) 43:631-635
360. Martha Jr PM, Goorman KM, Blizzard RM, Rogol AD, Veldhuis JD 1992 Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: relationship to age, pubertal status and body mass. J Clin Endocrinol Metab 74:336-344
361. Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y, Kangawa K 2005 Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90:6-9
362. Guan Z 2002 Identification and localization of the fatty acid modification in ghrelin by electron capture dissociation. J Am Soc Mass Spectrom 13:1443-1447
363. Banks WA, Tschop M, Robinson SM, Heiman ML 2002 Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827
364. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99:789-798
365. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
366. Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J 1998 Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 139:2272-2277
367. Ballare E, Persani L, Lania AG, Filopanti M, Giammona E, Corbetta S, Mantovani S, Arosio M, Beck-Peccoz P, Faglia G, Spada A 2001 Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86:3809-3814
368. Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen CH 2004 Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145:604-612
369. Zhang WH, Beaudet A, Tannenbaum GS 1999 Sexually dimorphic expression of sst1 and sst2 somatostatin receptor subtypes in the arcuate nucleus and anterior pituitary of adult rats. J Neuroendocrinol 11:129-136
370. Katakami H, Downs TR, Frohman LA 1988 Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Endocrinology 123:1103-1109
371. Csaba Z, Simon A, Helboe L, Epelbaum J, Dournaud P 2003 Targeting sst2A receptor-expressing cells in the rat hypothalamus through in vivo agonist stimulation: neuroanatomical evidence for a major role of this subtype in mediating somatostatin functions. Endocrinology 144:1564-1573
372. Aguila MC 1998 Somatostatin decreases somatostatin messenger ribonucleic acid levels in the rat periventricular nucleus. Peptides 19:1573-1579
373. Veldhuis JD, Anderson SM, Patrie JT, Bowers CY 2004 Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive. J Clin Endocrinol Metab 89:121-127
374. Chowen-Breed JA, Steiner RA, Clifton DK 1989 Sexual dimorphism and testosterone-dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain. Endocrinology 125:357-362
375. Herbison AE, Theodosis DT 1993 Absence of estrogen receptor immunoreactivity in somatostatin (SRIF) neurons of the periventricular nucleus but sexually dimorphic colocalization of estrogen receptor and SRIF immunoreactivities in neurons of the bed nucleus of the stria terminalis. Endocrinology 132:1707-1714
376. Slama A, Videau C, Kordon C, Epelbaum J 1992 Estradiol regulation of somatostatin receptors in the arcuate nucleus of the female rat. Neuroendocrinology 56:240-245
377. Kimura N, Tomizawa S, Arai KN, Kimura N 1998 Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 139:1573-1580
378. Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS, Veldhuis JD 2001 Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dosedependent inhibition of fasting growth hormone secretion. J Clin Endocrinol Metab 86:3143-3149
379. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws Jr ER 1998 Selective expression of estrogen receptor α and β isoforms in human pituitary tumors. J Clin Endocrinol Metab 83:3965-3972
380. de Zegher F, Devlieger H, Eggermont E, Veldhuis JD 1993 Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. J Clin Endocrinol Metab 76:1177-1181
381. Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS, Veldhuis JD 1994 Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 78:543-548
382. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL 1994 Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I: involvement of hypothalamic somatostatin. J Clin Invest 94:138-145
383. Hennessey AC, Wilson ME, Albers HE 1994 Somatostatin mRNA levels within the periventricular nucleus are regulated by estradiol and insulin-like growth factor-I in immature female rats. Mol Cell Neurosci 5:540-548
384. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I 2001 Estrogen receptor (ER) α, but not ER β, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus. Endocrinology 142:538-543
385. Fodor M, Oudejans CB, Delemarre-van de Waal HA 2001 Absence of androgen receptor in the growth hormone releasing hormonecontaining neurones in the rat mediobasal hypothalamus. J Neuroendocrinol 13:724-727
386. Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR 1987 The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120:1658-1662
387. Veldhuis JD, Anderson SM, Iranmanesh A, Bowers CY 2005 Testosterone blunts feedback inhibition of GH secretion by experimentally elevated IGF-I concentrations. J Clin Endocrinol Metab 90:1613-1617
388. Veldhuis JD, Anderson SM, Kok P, Iranmanesh A, Frystyk J, Orskov H, Keenan DM 2004 Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women. J Clin Endocrinol Metab 89:1312-1318
389. Bennett PA, Levy A, Carmignac DF, Robinson IC, Lightman SL 1996 Differential regulation of the growth hormone receptor gene: effects of dexamethasone and estradiol. Endocrinology 137:3891-3896
390. Ono M, Miki N, Murata Y, Osaki E, Tamitsu K, Ri T, Yamada M, Demura H 1995 Sexually dimorphic expression of pituitary growth hormone-releasing factor receptor in the rat. Biochem Biophys Res Comm 216:1060-1066
391. Gabrielsson BG, Carmignac DF, Flavell DM, Robinson ICAF 1995 Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acid in the rat. Endocrinology 136:209-217
392. Zheng H, Bailey A, Jiang MH, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LH, Schaeffer JM, Leng G, Smith RG 1997 Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol 11:1709-1717
393. Bergland R, Page RB 1978 Does the pituitary secrete to the brain? (affirmative anatomical evidence in 9 species). Endocrinology 102:1325-1338
394. Yamauchi N, Shibasaki N, Ling N, Demura H 1991 In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release. Regul Pept 33:71-78
395. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F 1996 An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81:2460-2466
396. Erickson D, Keenan DM, Farhy LS, Mielke K, Bowers CY, Veldhuis JD 2005 Determinants of dual secretagogue drive of burst-like GH secretion in premenopausal women studied under a selective estradiol clamp. J Clin Endocrinol Metab 90:1741-1751
397. Veldhuis JD, Erickson D, Mielke K, Farhy LS, Keenan DM, Bowers CY 2005 Distinctive inhibitory mechanisms of age and relative visceral adiposity on GH secretion in pre- and postmenopausal women studied under a hypogonadal clamp. J Clin Endocrinol Metab 90:6006-6013
398. Veldhuis JD, Patrie J, Wideman L, Patterson M, Weltman JY, Weltman A 2004 Contrasting negative-feedback control of endogenously driven and exercise-stimulated pulsatile growth hormone secretion in women and men. J Clin Endocrinol Metab 89:840-846
399. Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD 2001 Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86:551-560
400. Veldhuis JD, Evans WS, Bowers CY 2003 Estradiol supplementation enhances submaximal feedforward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu. J Clin Endocrinol Metab 88:5484-5489
401. Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD 2001 Estradiol supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion. J Clin Endocrinol Metab 86:5904-5911
402. Keenan DM, Veldhuis JD, Yang R 1998 Joint recovery of pulsatile and basal hormone secretion by stochastic nonlinear random-effects analysis. Am J Physiol 275:R1939-R1949
403. Keenan DM, Licinio J, Veldhuis JD 2001 A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. Proc Natl Acad Sci USA 98:4028-4033
404. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD 2003 Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis. Am J Physiol 285:R664-R673
405. Keenan DM, Alexander SL, Irvine CHG, Clarke IJ, Canny BJ, Scott CJ, Tilbrook AJ, Turner AI, Veldhuis JD 2004 Reconstruction of in vivo time-evolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements in interglandular signaling. Proc Natl Acad Sci USA 101:6740-6745
406. Keenan DM, Chattopadhyay S, Veldhuis JD 2005 Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood. J Theor Biol 236:242-255
407. Veldhuis JD, Carlson ML, Johnson ML 1987 The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84:7686-7690
408. Veldhuis JD, Evans WS, Johnson ML 1995 Complicating effects of highly correlated model variables on nonlinear least-squares estimates of unique parameter values and their statistical confidence intervals: estimating basal secretion and neurohormone half-life by deconvolution analysis. Meth Neurosci 28:130-138
409. Pincus SM, Keefe DL 1992 Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol 262:E741-E754
410. Pincus SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, Veldhuis JD 1996 Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci USA 93:14100-14105
411. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe CA, Barkan A, Johnson ML, Pincus SM 2001 Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol 280:R721-R729
412. Veldhuis JD, Johnson ML, Veldhuis OL, Straume M, Pincus S 2001 Impact of pulsatility on the ensemble orderliness (approximate entropy) of neurohormone secretion.AmJ Physiol 281:R1975-R1985
413. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD 1999 Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol 277:E948-E957
414. Veldhuis JD, Metzger DL, Martha Jr PM, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM 1997 Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414-3420
415. Giustina A, Scalvini T, Tassi C, Desenzani P, Poiesi C, Wehrenberg WB, Rogol A, Veldhuis JD 1997 Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab 82:1210-1219
416. Pincus SM, Veldhuis JD, Rogol AD 2000 Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys. Am J Physiol Endocrinol Metab 279:E417-E424
417. Zwart A, Iranmanesh A, Veldhuis JD 1997 Disparate serum free testosterone concentrations and degrees of hypothalamo-pituitary-LH suppression are achieved by continuous versus pulsatile intravenous androgen replacement in men: a clinical experimental model of ketoconazole-induced reversible hypoandrogenemia with controlled testosterone add-back. J Clin Endocrinol Metab 82:2062-2069
418. Loche S, Colao A, Cappa M, Bellone J, Aimaretti G, Farello G, Faedda A, Lombardi G, Deghenghi R, Ghigo E 1997 The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Metab 82:861-864
419. Frystyk J, Ivarsen P, Stoving RK, Dall R, Bek T, Hagen C, Orskov H 2001 Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res 11:117-127
420. Owen JB 1999 Genetic aspects of body composition. Nutrition 15:609-613
421. Salerno M, Balestrieri B, Matrecano E, Officioso A, Rosenfeld RG, Di Maio S, Fimiani G, Ursini MV, Pignata C 2001 Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 86:3882-3888
422. Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT 1997 Men homozygous for an inactivating mutation of the folliclestimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 15:205-206
423. Ellis JA, Stebbing M, Harrap SB 2001 Significant population variation in adult male height associated with the Y chromosome and the aromatase gene. J Clin Endocrinol Metab 86:4147-4150
424. Radetti G, Buzi F, Paganini C, Martelli C, Adami S 2000 A four year dose-response study of recombinant human growth hormone treatment of growth hormone deficient children: effects on growth, bone growth and bone mineralization. Eur J Endocrinol 142:42-46
425. Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 1999 Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 84:3064-3070
426. Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD 2002 Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab 87:825-834
427. Shah N, Evans WS, Veldhuis JD 1999 Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am J Physiol 276:R1351-R1358